News|Articles|November 18, 2025
Understanding Anti-Drug Antibody Assessment: Early Discovery through Clinical Trials
Author(s)Prolytix
Learn the unique considerations for use of ADA assays in early development, pre-clinical and clinical settings, as well as how to generate high-quality methods at each stage to support successful development and regulatory approval of safe and effective biotherapeutic drugs.
Related Content
Trending on Pharmaceutical Technology
1
Shilpa CDMO to Launch as Dedicated Complex Small-Molecule Contract Development and Manufacturing Brand at CPHI Milan
2
Technology Transfer: Success Drivers and Obstacles Explained
3
Assessment of Silicone Oil Cleaning on Indirect Surfaces in Aseptic Manufacturing
4
European Regulators Prepare the Pharma Industry for Future Changes as Legislation is Formalized
5